导航覆盖范围:一项定性研究,探讨保险公司政策对停止覆盖抗肥胖药物的感知影响
Treah Haggerty1, Patricia Dekeseredy2, Joanna Bailey3
1Department of Family Medicine, Director of Pediatric Medical Weight Management, West Virginia University, Morgantown, WV, 26506, USA.
由于失去了保险覆盖,患者停止服用抗肥胖药物,感到绝望和耻辱. 这凸显了需要更好的策略来管理医疗体重管理中的治疗中止.
科学领域:
- 医学科学 医学科学 医学科学
- 公共卫生 公共卫生
- 定性研究是指质量研究.
背景情况:
- 肥胖率的上升需要有效的治疗选择.
- 抗肥胖药物提供了显著的好处,但往往是昂贵的.
- 对于这些药物的保险覆盖范围的限制扰乱了患者的治疗.
研究的目的:
- 为了探索因保险驱动而停止服用抗肥胖药物的影响.
- 了解医疗减肥计划中的患者体验.
主要方法:
- 使用半结构面试进行的定性描述性研究.
- 采访了22名来自单一保险计划的女性患者.
- 使用定性内容分析来识别新出现的主题.
主要成果:
- 患者在失去药物覆盖后,经历了从希望转向绝望的转变.
- 对终止保险的愤怒和不公正的看法是普遍存在的.
- 医疗保健和保险系统中的耻辱是一个重要的主题.
结论:
- 由于覆盖率下降而停止服用抗肥胖药物被视为不公正和耻辱.
- 医疗保健提供者需要策略来应对保险限制和患者困境.
- 需要进一步的研究来支持面临治疗中断的患者.
更多相关视频
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
相关概念视频
Obesity
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
